Christopher Holroyd is a Consultant Rheumatologist at Southampton University Hospitals. Dr Holroyd graduated from the University of Southampton in 2000. Following this, his postgraduate rheumatology training was completed in the Wessex region, with accreditation in both rheumatology and internal medicine in 2010. During his training, Dr Holroyd completed 3 years as a clinical research fellow at the Medical Research Council, Lifecourse Epidemiology Unit, University Of Southampton.

Dr Holroyd was appointed as Consultant Rheumatologist in Southampton in 2012 and is currently lead consultant for the biological therapies service for patients with inflammatory arthritis. Dr Holroyd also provides a service to Moorgreen Hospital, and a visiting rheumatology service in Guernsey on a monthly basis.

Dr Holroyd's practice embraces all aspects of rheumatology including inflammatory rheumatic disease, osteoporosis, connective tissue disease, soft tissue rheumatism, spinal pain,and fibromyalgia. He is also interested in the use of musculoskeletal ultrasound in the diagnosis and treatment of arthritis.

The rheumatology department of University Hospital Southampton has received several awards for its work; most recently, the EULAR (European League Against Rheumatism) Centre of Excellence award 2015-2020.

Dr Holroyd's biological therapies service was awarded the British Society of Rheumatology Best Practice (Outstanding) award, and was recently selected to represent rheumatology at the House of Lords Innovation within the NHS event. Dr Holroyd has a keen research interest and has received awards from the National Osteoporosis Society and the International Osteoporosis Federation for his research into bone disease. He is also principle investigator on several international clinical trials